FDA Noticed Labeling Problems With Roxane Drugs Six Months Before Morphine Alert
This article was originally published in The Pink Sheet Daily
Executive Summary
Roxane's high-potency morphine packaging is being redesigned with bold colors to distinguish it from other products after overdoses including deaths.
You may also be interested in...
Roxane's Redesigned Morphine Carton Reflects Orderly Rollout After Safety Concern
FDA allows existing stock to be used up over the course of a year after the new color-coded container for the high-potency product was approved.
Roxane's Redesigned Morphine Carton Reflects Orderly Rollout After Safety Concern
FDA allows existing stock to be used up over the course of a year after the new color-coded container for the high-potency product was approved.
Dangerous Clutter: FDA Takes On Errors Caused By Drug Labels, Packaging
Reducing the amount of unnecessary information on drug labels is one of several key ways to stop dangerous medication errors, a panel that is helping FDA develop guidance on the subject agreed